| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Prucalopride |
| Brand | Resolor® |
| Indication | For the symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. |
| Assessment Process | |
| Rapid review commissioned | 17/01/2011 |
| Rapid review completed | 29/03/2011 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |
Prucalopride (Resolor®) is to be reimbursed under the Community Drugs Schemes subject to conditions.